| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
27,434.69 | 27,890.26 | 26,986.63 | 31,507.72 | 33,646.03 |
| Cost of Revenue
|
-24,419.84 | -23,764.38 | -25,926.45 | -32,107.31 | -29,830.71 |
|
Gross Profit
|
3,014.85 | 4,125.88 | 1,060.18 | -599.59 | 3,815.32 |
|
Selling, General and Administrative Expenses
|
-5,619.13 | -5,662.12 | -6,224.23 | -5,237.66 | -4,992.52 |
|
Operating Income/Expenses
|
-5,619.13 | -5,662.12 | -6,224.23 | -5,237.66 | -4,992.52 |
|
Total Operating Profit/Loss
|
-2,604.28 | -1,536.24 | -5,164.05 | -5,837.25 | -1,177.20 |
| Total Net Finance Income/Expense
|
18.37 | 18.37 | 118.13 | 103.23 | 55.33 |
| Irregular Income/Expenses
|
339.52 | 339.52 | 0 | 0 | 4,738.39 |
|
Other Income/Expense, Non-Operating
|
-289.24 | 0.04 | 2.53 | 5 | 36.10 |
|
Non-Operating Income/Expenses, Total
|
68.66 | 357.93 | 120.67 | 108.23 | 4,829.83 |
|
Pretax Income
|
-2,535.63 | -1,178.31 | -5,043.39 | -5,729.01 | 3,652.63 |
|
Provision for Income Tax
|
94.83 | 95.10 | -572.23 | 1,327.43 | -785 |
|
Net Income from Continuing Operations
|
-2,440.80 | -1,083.21 | -5,615.61 | -4,401.58 | 2,867.63 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-2,440.80 | -1,083.21 | -5,615.61 | -4,401.58 | 2,867.63 |
|
Net Income after Non-Controlling/Minority Interests
|
-2,440.80 | -1,083.21 | -5,615.61 | -4,401.58 | 2,867.63 |
|
Net Income Available to Common Stockholders
|
-2,440.80 | -1,083.21 | -5,615.61 | -4,401.58 | 2,867.63 |
|
Diluted Net Income Available to Common Stockholders
|
-2,440.80 | -1,083.21 | -5,615.61 | -4,401.58 | 2,867.63 |
|
Common Dividend per Share
|
0.09 | 0.12 | 0.33 | 0.64 | 0.88 |
| Basic EPS
|
-2.53 | -1.12 | -5.81 | -4.56 | 2.97 |
| Diluted EPS
|
-2.53 | -1.12 | -5.81 | -4.56 | 2.97 |
|
Basic Weighted Average Shares Outstanding
|
966.13 | 966.13 | 966.13 | 966.13 | 966.13 |
|
Diluted Weighted Average Shares Outstanding
|
966.13 | 966.13 | 966.13 | 966.13 | 966.13 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-2,535.63 | -1,196.68 | -5,161.52 | -5,832.24 | 3,597.30 |
|
EBITDA
|
-1,356.52 | 20.97 | -3,988.04 | -4,557.16 | 4,877.17 |
|
Normalized EBITDA
|
-1,696.04 | -326.07 | -4,064.01 | -4,607.59 | 136.07 |
|
Normalized Income
|
-2,767.62 | -1,402.14 | -5,672.11 | -4,440.31 | -854.13 |
|
Total Unusual Items
|
-339.52 | -347.04 | -75.97 | -50.42 | -4,741.10 |
|
Total Unusual Items Excluding Goodwill
|
-339.52 | -347.04 | -75.97 | -50.42 | -4,741.10 |
|
Tax Effect of Unusual Items
|
-12.70 | -28.11 | -19.47 | -11.70 | -1,019.34 |
12/31/2022 - 2/23/1973
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade